Company intelligence / Profile preview

G Square Capital

London, England, United Kingdom

Ownership: Private
Employees: ~36
Development stage: Other

Overview

G Square is a London-based private equity investment firm focused exclusively on the healthcare sector, primarily across Europe. The firm invests in mid-market healthcare businesses rather than developing its own therapeutics, and targets areas such as medical products, digital health, healthcare services, and services to the pharmaceutical industry. G Square combines sector-specialist investing with operational support and value-creation capabilities to help portfolio companies scale and transform. It is an active, regulated investment manager rather than a drug developer, CRO, or operating biopharma company.

Industry: Investors

Partnerships

G21

Beyond the preview

Go deeper on G Square Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on G Square Capital.

Explore the full profile